a16z | The Future Of Miracle Drugs @a16z | Uploaded December 2023 | Updated October 2024, 1 hour ago.
In 2023, a wave of therapies hailed as miracle drugs — including curative cell and gene therapies — had a profound impact on patients’ lives.
Yet, our current insurance system is still not set up to bear the cost of these therapies, and our healthcare providers are still not prepared to manage the associated logistical complexities.
On the a16z podcast, we’re joined by Julie Yoo, general partner at a16z, to discuss the challenges associated with miracle drugs as well as the opportunities they present in 2024 and beyond.
FULL EPISODE: youtu.be/iMQw5WTwWF0
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
In 2023, a wave of therapies hailed as miracle drugs — including curative cell and gene therapies — had a profound impact on patients’ lives.
Yet, our current insurance system is still not set up to bear the cost of these therapies, and our healthcare providers are still not prepared to manage the associated logistical complexities.
On the a16z podcast, we’re joined by Julie Yoo, general partner at a16z, to discuss the challenges associated with miracle drugs as well as the opportunities they present in 2024 and beyond.
FULL EPISODE: youtu.be/iMQw5WTwWF0
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
